| Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT AM Risitano, S Marotta, P Ricci, L Marano, C Frieri, F Cacace, M Sica, ... Frontiers in immunology 10, 1157, 2019 | 202 | 2019 |
| Eltrombopag added to immunosuppression in severe aplastic anemia R Peffault de Latour, A Kulasekararaj, S Iacobelli, SR Terwel, R Cook, ... New England Journal of Medicine 386 (1), 11-23, 2022 | 196 | 2022 |
| Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2 … AM Risitano, A Röth, J Soret, C Frieri, FS de Fontbrune, L Marano, ... The Lancet Haematology 8 (5), e344-e354, 2021 | 96 | 2021 |
| Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned AM Risitano, S Marotta, R Calzone, F Grimaldi, A Zatterale haematologica 101 (3), 319, 2016 | 67 | 2016 |
| Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria AM Risitano, S Marotta American journal of hematology 93 (4), 564-577, 2018 | 58 | 2018 |
| Eltrombopag for post-transplant cytopenias due to poor graft function S Marotta, L Marano, P Ricci, F Cacace, C Frieri, L Simeone, F Trastulli, ... Bone Marrow Transplantation 54 (8), 1346-1353, 2019 | 56 | 2019 |
| Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy J Mariotti, AM Raiola, A Evangelista, AM Carella, M Martino, F Patriarca, ... Blood advances 4 (16), 3900-3912, 2020 | 51 | 2020 |
| Impact of HLA disparity in haploidentical bone marrow transplantation followed by high-dose cyclophosphamide AM Raiola, A Risitano, N Sacchi, L Giannoni, A Signori, S Aquino, ... Biology of Blood and Marrow Transplantation 24 (1), 119-126, 2018 | 51 | 2018 |
| Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future AM Risitano, S Marotta Seminars in Immunology 28 (3), 223-240, 2016 | 51 | 2016 |
| Letermovir prophylaxis for cytomegalovirus infection in allogeneic stem cell transplantation: a real-world experience M Martino, A Pitino, M Gori, B Bruno, A Crescimanno, V Federico, ... Frontiers in oncology 11, 740079, 2021 | 30 | 2021 |
| Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Eltrombopag added to immunosuppression in severe aplastic anemia R Peffault de Latour, A Kulasekararaj, S Iacobelli, SR Terwel, R Cook, ... N Engl J Med 386 (1), 11-23, 2022 | 28 | 2022 |
| Safety and pharmacokinetics of the complement inhibitor TT30 in a phase I trial for untreated PNH patients AM Risitano, M Storek, L Sahelijo, M Doyle, Y Dai, IC Weitz, JCW Marsh, ... Blood 126 (23), 2137, 2015 | 27 | 2015 |
| Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis S Pagliuca, AM Risitano, FS De Fontbrune, M Robin, AP Iori, S Marotta, ... Bone Marrow Transplantation 53 (1), 105-107, 2018 | 18 | 2018 |
| Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations S Marotta, S Pagliuca, AM Risitano Expert review of hematology 7 (6), 775-789, 2014 | 18 | 2014 |
| Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions S Thota, BJ Patel, M Sadaps, S Balasubramanian, S Sanikommu, ... British journal of haematology 183 (1), 133, 2017 | 14 | 2017 |
| Excellent outcome of concomitant intensive immunosuppression and eculizumab in aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome S Marotta, G Giagnuolo, S Basile, S Pagliuca, F Grimaldi, F Pane, ... J Hematol Thromb Dis 2 (1), 128, 2014 | 14 | 2014 |
| Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant … D Pastore, B Bruno, P Carluccio, MS De Candia, S Mammoliti, ... Annals of Hematology 99, 867-875, 2020 | 11 | 2020 |
| ‘Real-life’report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) L Giaccone, G Mancini, N Mordini, G Gargiulo, V De Cecco, S Angelini, ... Bone Marrow Transplantation 53 (1), 58-63, 2018 | 7 | 2018 |
| Acute immune toxicity during anti‐thymocyte globulin: That's CARPA! S Marotta, P Ricci, L Marano, G Beneduce, O Vitagliano, F De Gregorio, ... American Journal of Hematology 93 (1), E22-E24, 2018 | 2 | 2018 |
| Alemtuzumab for aplastic anemia and related immune-mediated bone marrow failures: long-term follow up of a pilot study A Risitano, C Selleri, B Serio, L Marando, S Marotta, M Raia, R De Palma, ... Haematologica, 2011 | 2 | 2011 |
